Russo Partners

Russo Partners is a specialized public relations and investor relations firm serving the healthcare and technology sectors. Founded in 1988, the company has established itself as a communications partner for biopharmaceutical companies, medical device manufacturers, and healthcare technology innovators across all stages of their corporate lifecycle.

The firm offers integrated communications services including media relations, investor relations, regulatory communications, social and digital media management, clinical trial recruitment support, and crisis management. Their proprietary MAP (Messaging and Positioning) methodology provides audit-based message platform development. A distinctive offering is their Sports-Health Alliance program, which connects professional athletes with healthcare advocacy campaigns to drive awareness and patient engagement.

The agency's leadership team brings over three decades of experience in healthcare communications, with expertise spanning Wall Street financial communications, media relations with major publications, and video production capabilities led by a former ABC News senior producer. Russo Partners works globally with clients ranging from early-stage startups to established pharmaceutical companies.

Organizations should consider Russo Partners when they need communications counsel that understands both the scientific complexity of healthcare innovation and the expectations of Wall Street investors. The firm's 36-year track record in the sector provides established media relationships and regulatory communications expertise that can accelerate visibility for clinical milestones and corporate developments.

The agency's integrated model means clients work with a team that coordinates messaging across public relations, investor relations, and digital channels to maintain consistency. Their Sports-Health Alliance offers a differentiated approach for patient-facing campaigns, particularly for orthopedic, sports medicine, and lifestyle health initiatives.

Russo Partners operates exclusively in the healthcare and technology sectors, with particular depth in biopharmaceuticals, medical devices, and healthcare technology. The firm's healthcare specialization includes regulatory communications expertise for FDA processes, clinical trial recruitment support, and relationships with healthcare trade media including Endpoints News and Fierce Biotech.

Their team includes scientists and former healthcare journalists who understand the technical aspects of drug development, medical devices, and health technology. The agency has managed communications for COVID-19 vaccine developers, gene editing partnerships, and innovative therapies across multiple therapeutic areas.

The ideal client is a biopharmaceutical company, medical device manufacturer, or healthcare technology firm with significant news to communicate—whether clinical trial results, regulatory milestones, financing rounds, or product launches. Organizations benefit most when they need sophisticated investor relations counsel alongside public relations, particularly those preparing for or managing public company status.